Use of Etest to assess synergy of antibiotic combinations against clinical isolates of Pseudomonas spp.
作者信息
Fodor E, Hajdú E, Nagy E
出版信息
Int J Antimicrob Agents. 2005 Feb;25(2):183-4. doi: 10.1016/j.ijantimicag.2004.11.004.
Abstract
摘要
相似文献
1
Use of Etest to assess synergy of antibiotic combinations against clinical isolates of Pseudomonas spp.
Int J Antimicrob Agents. 2005 Feb;25(2):183-4. doi: 10.1016/j.ijantimicag.2004.11.004.
2
In vitro activities of non-traditional antimicrobials alone or in combination against multidrug-resistant strains of Pseudomonas aeruginosa and Acinetobacter baumannii isolated from intensive care units.非传统抗菌药物单独或联合使用对从重症监护病房分离出的多重耐药铜绿假单胞菌和鲍曼不动杆菌菌株的体外活性。
Int J Antimicrob Agents. 2006 Mar;27(3):224-8. doi: 10.1016/j.ijantimicag.2005.10.012. Epub 2006 Feb 7.
3
Determination of the synergy of antibiotic combinations by an overlay inoculum susceptibility disc method.
Arzneimittelforschung. 1991 Feb;41(2):148-50.
4
In vitro activity of azithromycin as an antipseudomonal agent.
Indian J Pathol Microbiol. 2006 Oct;49(4):634-5.
5
Pseudomonas aeruginosa infections in the Intensive Care Unit: can the adequacy of empirical beta-lactam antibiotic therapy be improved?重症监护病房中的铜绿假单胞菌感染：经验性β-内酰胺类抗生素治疗的充分性能否得到改善？
Int J Antimicrob Agents. 2007 Nov;30(5):458-62. doi: 10.1016/j.ijantimicag.2007.05.022. Epub 2007 Aug 20.
6
Etest synergy testing of clinical isolates of Staphylococcus aureus demonstrating heterogeneous resistance to vancomycin.金黄色葡萄球菌临床分离株对万古霉素呈异质性耐药的Etest协同试验。
Diagn Microbiol Infect Dis. 2006 Jan;54(1):73-7. doi: 10.1016/j.diagmicrobio.2005.08.014.
7
Antimicrobial susceptibility of Pseudomonas aeruginosa isolates obtained from patients in Canadian intensive care units as part of the Canadian National Intensive Care Unit study.作为加拿大国家重症监护病房研究的一部分，从加拿大重症监护病房患者中分离出的铜绿假单胞菌菌株的抗菌药敏性。
Diagn Microbiol Infect Dis. 2008 Jun;61(2):217-21. doi: 10.1016/j.diagmicrobio.2008.01.009. Epub 2008 Mar 4.
8
Clinical, microbiologic, and epidemiologic characteristics of Pseudomonas aeruginosa infections in a University Hospital, Malatya, Turkey.土耳其马拉蒂亚市一家大学医院铜绿假单胞菌感染的临床、微生物学和流行病学特征
Am J Infect Control. 2006 May;34(4):188-92. doi: 10.1016/j.ajic.2005.11.010.
9
Clinical utility of synergy testing for multidrug-resistant Pseudomonas aeruginosa isolated from patients with cystic fibrosis: 'the motion for'.从囊性纤维化患者中分离出的多重耐药铜绿假单胞菌协同试验的临床效用：“支持……的动议”
Paediatr Respir Rev. 2007 Sep;8(3):249-55. doi: 10.1016/j.prrv.2007.04.006. Epub 2007 Jun 5.
10
[Use of new antibiotics in the treatment of Pseudomonas infections. I. In vitro tests].[新型抗生素在铜绿假单胞菌感染治疗中的应用。I. 体外试验]
Rev Clin Esp. 1969 May 15;113(3):235-40.
引用本文的文献
1
In Vitro Synergy of Levofloxacin Plus Piperacillin/Tazobactam against Pseudomonas aeruginosa.左氧氟沙星联合哌拉西林/他唑巴坦对铜绿假单胞菌的体外协同作用
Interdiscip Perspect Infect Dis. 2009;2009:984934. doi: 10.1155/2009/984934. Epub 2009 Nov 8.
Zotero 插件